Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders

Neuropsychopharmacology. 1999 Aug;21(2 Suppl):91S-98S. doi: 10.1016/S0893-133X(99)00036-6.

Abstract

The therapeutic effectiveness of antidepressant drugs in major depression was discovered by pure serendipity. It took over 20 years before the neurobiological modifications that could mediate the antidepressive response were put into evidence. Indeed, whereas the immediate biochemical effects of these drugs had been well documented, their antidepressant action generally does not become apparent before 2 to 3 weeks of treatment. The different classes of antidepressant treatments were subsequently shown to enhance serotonin neurotransmission albeit via different pre- and postsynaptic mechanisms. Clinical trials based on this hypothesis led to the development of treatment strategies producing greater efficacy and more rapid onset of antidepressant action; that, is lithium addition and pindolol combination, respectively. It is expected that the better understanding recently obtained of the mechanism of action of certain antidepressant drugs in obsessive-compulsive and panic disorders will also lead to more effective treatment strategies for those disorders.

Publication types

  • Review

MeSH terms

  • Animals
  • Antidepressive Agents / therapeutic use*
  • Clinical Trials as Topic
  • Depressive Disorder / drug therapy*
  • Depressive Disorder / metabolism
  • Depressive Disorder / physiopathology
  • Humans
  • Models, Neurological
  • Neurons / physiology
  • Obsessive-Compulsive Disorder / drug therapy*
  • Obsessive-Compulsive Disorder / metabolism
  • Obsessive-Compulsive Disorder / physiopathology
  • Panic Disorder / drug therapy*
  • Panic Disorder / metabolism
  • Panic Disorder / physiopathology
  • Receptors, Serotonin / physiology*
  • Serotonin / physiology*
  • Synaptic Transmission / drug effects

Substances

  • Antidepressive Agents
  • Receptors, Serotonin
  • Serotonin